Simple Summary The high lethality of colorectal cancer (CRC) is anticipated to continue in
the following decades. Early-stage CRC is entirely treatable with surgery and adjuvant …

Paclitaxel is a broad‐spectrum anticancer compound, which was derived mainly from a
medicinal plant, in particular, from the bark of the yew tree Taxus brevifolia Nutt. It is a …

Background & Aims There were an estimated 4.8 million new cases of gastrointestinal (GI)
cancers and 3.4 million related deaths, worldwide, in 2018. GI cancers account for 26% of …

According to GLOBOCAN 2018 data, colorectal cancer (CRC) is the third most deadly and
fourth most commonly diagnosed cancer in the world. Nearly 2 million new cases and about …

The Mediterranean diet (MedDiet), abundant in minimally processed plant-based foods, rich
in monounsaturated fat from olive oil, but lower in saturated fat, meats, and dairy products …

Colorectal Cancer is the third most common cancer diagnosed in the US. While the
incidence and the mortality rate of colorectal cancer has decreased due to effective cancer …

Colorectal cancer (CRC) is the third most common cancer worldwide and the fourth most
common cause of cancer death. Predictions of the future burden of the disease inform health …

In contrast to the decreasing incidence of colorectal cancer (CRC) in older populations, the
incidence has nearly doubled in younger adults since the early 1990s. Approximately 1 in …

Objective The global burden of colorectal cancer (CRC) is expected to increase by 60% to
more than 2.2 million new cases and 1.1 million deaths by 2030. In this study, we aim to …

Gastrointestinal (GI) cancers, including colorectal cancer, gastric cancer, and esophageal
cancer, are a major medical and economic burden worldwide and have the largest number …